Top Markets
Coin of the day
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.

Yumanity Therapeutics, Inc.

YMTX
Rang în acțiuni #28846
Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical... Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical company. Its primary focus lies in the investigation and development of therapeutic solutions for neurodegenerative conditions, particularly those driven by protein misfolding. The firm aims to discover disease-modifying treatments for a range of neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis (ALS), and frontotemporal lobar degeneration. Central to its pipeline is YTX-7739, an innovative small molecule presently in Phase I clinical trials for Parkinson's disease and associated α-synuclein disorders. Additionally, YTX-9184 is undergoing preclinical studies with the goal of treating diverse neurological conditions. The company maintains a license and research collaboration agreement with Merck Sharp & Dohme Corp. Founded in 2014, Yumanity Therapeutics Inc. is headquartered in Boston, Massachusetts.
Preț acțiune
$1.89
Ultima sincronizare: 2022-12-16
Capitalizare de piață
$24.38M
Schimbare (1 zi)
8.62%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Yumanity Therapeutics, Inc. (YMTX)

Categorie

Istoric al prețului acțiunii pentru Yumanity Therapeutics, Inc. (YMTX)
Cel mai mare preț de închidere: $1.94 pe 2022-12-01

Cel mai mic preț de închidere: $18.35 pe 2020-12-01
Istoric al prețului acțiunii pentru Yumanity Therapeutics, Inc. din 2020 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2022 -41.89%
2021 -81.82%
2020 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$551.16 41.05%
US
$163.88 487.17%
US
$1.03K 57.08%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH